From: Correlation of MLH1 and MGMTexpression and promoter methylation with genomic instability in patients with thyroid carcinoma
Methylated and MSI
PTC
FTC
Benign
N (%)
MLH1
24/31 (77%)*
3/4 (75%)
4/9 (44%)
MGMT
38/45 (84%)**
7/8 (87%)
3/8 (37%)